ACHP Letter to Dr. Oz on Commonsense Deregulation in Medicare Advantage and Part D
ACHP urges CMS to cut red tape, lower costs and promote choice in Medicare Advantage.
ACHP urges CMS to cut red tape, lower costs and promote choice in Medicare Advantage.
ACHP sent a letter to the Department of Justice with recommendations for the Anticompetitive Regulations Task Force.
ACHP issued a statement in response to an announcement from CMS on increasing risk adjustment audits in Medicare Advantage
ACHP commends the Trump Administration for finalizing policies in the 2026 MA and Part D Rate Notice that reflect higher care delivery costs and for taking another step toward reining in aggressive risk adjustment to boost competition.
ACHP President and CEO Ceci Connolly released a statement in response to CMS’ final CY2026 Medicare Advantage and Part D rule.
